|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
LifeMap Sciences, a Subsidiary of BioTime (BTX), Announces Release of GeneCards® Version 3.09
11/19/2012 9:39:04 AM
ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.09, on November 18, 2012. The new release is available at www.genecards.org. LifeMap Sciences holds the exclusive worldwide license to market GeneCards® from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science. GeneCards® is a comprehensive online database that provides concise genomic information on all known and predicted human genes. The recent GeneCards® release greatly enhances the representation of non-protein coding RNA genes based, among other sources, on the ENCODE Project, an international collaborative effort to identify all functional elements in the human genome sequence. With over 12 million page visits per year from hundreds of thousands of unique users worldwide, GeneCards® is accessed by professionals in academia, research hospitals, patent offices, and leading biotech and pharma companies. GeneCards® was developed, and is continuously enhanced by ongoing research, by the bioinformatics team at the Department of Molecular Genetics at the Weizmann Institute of Science in Israel, with principal investigator Professor Doron Lancet, head of the Crown Human Genome Center, and team leader Marilyn Safran.
|
|
|
|
|
|
|
|
|
|
|